Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,773-8,784 of 10,592
Device study icon
CompletedNCT01841970

Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids

This study exists to see whether the medication HET can play a useful role in care. Researchers are trying to understand whether the medication HET can better prevent setbacks and support longer-term stability.

In United States
BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 21 Years
Countries
United States
Sponsor
Medtronic - MITG
Condition
Bipolarity
Drug study icon
CompletedNCT01166425

Safety and Efficacy Study of Lithium for Pediatric Mania.

This summary needs review. Please check the official study record and contact the research team for details.

In United States
BipolarityDrugFrom 7 Years to 17 Years
Countries
United States
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition
Bipolarity
Drug study icon
TerminatedNCT01677182

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolarity type I

This study exists to explore whether the medication Ramelteon could improve care and understanding. Researchers are trying to understand whether the medication Ramelteon can give earlier or clearer feedback during care.

In United States
BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Takeda
Condition
Bipolarity
Behavioral study icon
CompletedNCT02466425

Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication SHP465 offers something meaningfully different. Researchers are trying to understand how people respond to the medication SHP465 in practice and what may need to be adjusted.

In United States
ADHDBehavioralFrom 6 Years to 17 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT00060489

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Depression for depression in bipolarity

This study is completed in the United States. It is testing Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Depression for depression in bipolarity.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.